KARPAS 231 Human B-cell Leukaemia cell line

Code: CL9

KARPAS 231 Human B-cell Leukaemia cell line useful in oncology research, developed at the University of Cambridge.


Nacheva et al. (1993). Blood 82, 231–240

Galieque Zouitina et al. (1996). Leukemia 10, 579–587

Willis et al. (1997). Blood 90, 2456–2464

Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. We have partnered with ECACC (The European Collection of Cell Cultures; a Public Health England Culture Collection) to manage distribution of the majority of these cells on our behalf. Enquires to either organisation are welcomed.

Make an Enquiryread more arrow

Enquiry for KARPAS 231 Human B-cell Leukaemia cell line

Reagents Enquiry

To find out more about how this website collects your personal data see www.enterprise.cam.ac.uk/about-us/information-compliance/data-protection/core-privacy-notices/website-users-use-personal-information/
  • In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. A backup of your data will be held but only authorised individuals will be able to access your data. If you would like your data to be removed, please email support@thewebkitchen.co.uk.